Tizzani A, Casetta G, Gontero P, Giammò A, Ghabin H, Demurtas S, Pacchioni D
University of Turin.
Minerva Urol Nefrol. 1997 Sep;49(3):141-3.
Using flow cytometry, gross genomic alterations, defined as DNA ploidy, and the fraction of S-phase cells, can be calculated in bladder cancer cells. In aneuploid superficial bladder cancer the recurrence rate has been reported to be three times higher than in diploid forms. A correlation between the S-phase fraction and progression has been reported for G1-G2/Ta-T1 tumours, but not for G3/Ta-T1. The aim of our study is to evaluate whether the traditional cytometric parameters can be used as valid predictors of early recurrences and progression in G1-G2/Ta-T1 and G3/Ta-T1 bladder cancer patients and to compare the proliferation indexes as defined by S-phase fraction and 67Ki monoclonal antibody in the two groups of patients.
运用流式细胞术,可在膀胱癌细胞中计算出总体基因组改变(定义为DNA倍性)以及S期细胞比例。据报道,非整倍体浅表性膀胱癌的复发率比二倍体形式高两倍。对于G1-G2/Ta-T1肿瘤,已报道S期比例与进展之间存在相关性,但G3/Ta-T1肿瘤不存在这种相关性。我们研究的目的是评估传统细胞计量学参数是否可作为G1-G2/Ta-T1和G3/Ta-T1膀胱癌患者早期复发和进展的有效预测指标,并比较两组患者中由S期比例和67Ki单克隆抗体定义的增殖指数。